Generic Name and Formulations:
Triazolam 0.125mg, 0.25mg+; tabs; +scored.
Indications for HALCION:
Short-term (7–10 days) treatment of insomnia.
Use lowest effective dose. ≥18yrs: 0.125–0.25mg at bedtime; max 0.5mg. Elderly and/or debilitated: initially 0.125mg; max 0.25mg. Max 1 month/℞.
<18yrs: not established.
Concomitant ketoconazole, itraconazole, nefazodone, HIV protease inhibitors (eg, ritonavir, indinavir, nelfinavir, saquinavir, lopinavir), other potent CYP3A inhibitors. Pregnancy (Cat.X).
Risks from concomitant use with opioids; see Interactions. Suicidal tendencies. Depression. Pulmonary, renal, or hepatic disease. Sleep apnea. Discontinue if excitement or daytime anxiety occurs. Drug or alcohol abuse. Overdosage may occur at 2mg. Reevaluate if used ≥2–3 weeks. Avoid abrupt cessation. Monitor periodic CBCs, urinalysis, blood chemistry. Nursing mothers: not recommended.
See Contraindications; other azole antifungals: not recommended. Increased sedation, respiratory depression, coma, and death with concomitant opioids; reserve use in those for whom alternative treatment options are inadequate; if needed, limit dosages/durations to minimum and monitor. Additive CNS depressant effects with alcohol or other CNS depressants (eg, other benzodiazepines, TCAs, psychotropics, anticonvulsants, antihistamines); consider dose reductions. Potentiated by ranitidine, grapefruit juice, isoniazid, oral contraceptives. Reduce triazolam dose with cimetidine, erythromycin, clarithromycin, other macrolides. Caution with fluvoxamine, diltiazem, verapamil, sertraline, paroxetine, ergotamine, cyclosporine, amiodarone, nicardipine, nifedipine, others metabolized by CYP3A.
Drowsiness, headache, dizziness, nervousness, light-headedness, ataxia, nausea, vomiting; worsening of insomnia, sleep-driving and other complex behaviors, paradoxical excitement, anxiety, abnormal behavior, amnesia, anaphylaxis, angioedema.
Endocrinology Advisor Articles
- ACP Defends Higher Blood Glucose Targets for Type 2 Diabetes
- Updated Clinical Practice Guidelines on Testosterone Therapy in Men With Hypogonadism
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Once-Daily Oral Contraceptive for Men Shows Promise
- HbA1c Levels Affect Serum Phospholipids, Inflammation inT2D, CVD
- American College of Physicians Releases 4 Guidelines for HbA1c Targets in T2D
- Dyslipidemia Drug Indications
- No Difference in Weight Loss Outcomes With Low-Fat vs Low-Carbohydrate Diet
- Damaging Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture
- Gastric Bypass Surgery Linked to Increased Risk for Nonvertebral Fractures
- Common Plant-Derived Oils May Contain Endocrine-Disrupting Chemicals
- Red Meat Consumption Linked to Insulin Resistance and Steatohepatitis
- Effect of High Androgen Levels on Cardiovascular Risk in Postmenopausal Women
- Fertility in Women Negatively Affected by Asthma Medications
- Glucocorticoid Use in COPD Does Not Increase Fracture Risk